Clinic
Dignity Health
Dignity Health was paid $8.28M by Medicaid between Aug 2018 and Dec 2024, across 67 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 90% of everything it billed.
33Billing provider infoDIGNITY HEALTH
COTTONWOOD, CA 96022
COTTONWOOD, CA 96022
33aNPI1235672403assigned 11/21/2016
33bProvider typeRural Health Clinic/Center
28Total paid$8.28M
24GClaims184,651
24DCodes billed67
24AFirst – last monthAug 2018 – Dec 2024
Compared with peers
Next to other Rural Health Clinic/Center providers in California
Rank by total paid#59 of 215
Median peer was paid$3.62M
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MIRANDA, KIM controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,835 | $434K | |
| 2019 | 32,325 | $1.46M | |
| 2020 | 33,390 | $1.59M | |
| 2021 | 31,677 | $1.50M | |
| 2022 | 21,161 | $982K | |
| 2023 | 27,524 | $1.32M | |
| 2024incomplete | 28,739 | $980K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 90% | 45,073 | 40,937 | $7.47M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.9% | 38,228 | 21,069 | $241K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.5% | 25,821 | 14,590 | $210K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 4,019 | 2,206 | $49K |
| G9920 | Screening performed and negative | <1% | 2,779 | 1,605 | $39K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 3,609 | 1,994 | $39K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,946 | 1,070 | $29K |
| 92551 | <1% | 9,401 | 5,156 | $28K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,326 | 1,452 | $27K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 601 | 349 | $18K |
| 90686 | <1% | 2,905 | 1,768 | $15K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,522 | 983 | $14K |
55 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,958 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,332 | $11K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,193 | $9K |
| 90670 | <1% | 1,405 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 435 | $6K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,962 | $5K |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 275 | $4K |
| 90651 | <1% | 565 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 192 | $4K |
| 99173 | <1% | 6,623 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 113 | $3K |
| 90648 | <1% | 738 | $3K | |
| 90698 | <1% | 703 | $3K | |
| 96127 | <1% | 1,211 | $3K | |
| 90734 | <1% | 370 | $3K | |
| 90633 | <1% | 643 | $3K | |
| 81003 | <1% | 2,263 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 170 | $2K |
| 90723 | <1% | 466 | $2K | |
| G0467 | Community health center visit, returning patient | <1% | 216 | $2K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 51 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 272 | $1K |
| 90744 | <1% | 346 | $1K | |
| 90677 | <1% | 144 | $962.12 | |
| 90680 | <1% | 160 | $713.63 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 42 | $682.20 |
| 90656 | <1% | 102 | $661.24 | |
| 99283 | Emergency room visit (moderate) | <1% | 98 | $623.23 |
| 99188 | <1% | 67 | $468.00 | |
| 90715 | <1% | 90 | $462.77 | |
| 99381 | <1% | 15 | $373.16 | |
| 93000 | <1% | 49 | $348.49 | |
| 90696 | <1% | 94 | $344.46 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 77 | $338.92 |
| 90710 | <1% | 72 | $289.80 | |
| 90707 | <1% | 67 | $282.40 | |
| 90681 | <1% | 107 | $244.94 | |
| 81025 | <1% | 158 | $235.93 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 224 | $195.45 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 26 | $138.08 |
| 90716 | <1% | 22 | $81.98 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,224 | $4.93 |
| 1036F | 0% | 1,623 | $0.00 | |
| 3074F | 0% | 2,239 | $0.00 | |
| 3075F | 0% | 232 | $0.00 | |
| 3008F | 0% | 1,879 | $0.00 | |
| 3079F | 0% | 304 | $0.00 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 0% | 29 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 16 | $0.00 |
| 3080F | 0% | 18 | $0.00 | |
| 3078F | 0% | 2,249 | $0.00 | |
| 3077F | 0% | 116 | $0.00 | |
| 3725F | 0% | 128 | $0.00 | |
| 1159F | 0% | 124 | $0.00 | |
| 1160F | 0% | 124 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMIRANDA, KIM (CHIEF FINANCIAL OFFICER)
Parent organizationDIGNITY HEALTH
| Provider | Location | Paid |
|---|---|---|
| Alameda Health System | Oakland, CA | $64.53M |
| Alameda Health System | Oakland, CA | $57.80M |
| Dignity Health | Red Bluff, CA | $28.47M |
| Dignity Health | Red Bluff, CA | $4.59M |
| Dignity Health | Mount Shasta, CA | $2.82M |
| Dignity Health | Redding, CA | $1.58M |
| Dignity Health | Redding, CA | $1.34M |
| Dignity Health | Mount Shasta, CA | $1.28M |
| Dignity Health | Weed, CA | $981K |
| Alameda Health System | Hayward, CA | $392K |
| Dignity Health | Redding, CA | $273K |
| Dignity Health | Red Bluff, CA | $134K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.